Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database

Abstract Objective Poly ADP‐ribose polymerase inhibitors (PARPis) have significantly improved clinical effects in gynecological oncology. However, PARPis could also induce severe organ system toxicities, including the hematological system. Our study aimed to extensively characterize the hematologica...

Full description

Bibliographic Details
Main Authors: Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
adverse event
disproportionality analysis
FAERS database
hematological toxicities
PARP inhibitor
Online Access:https://doi.org/10.1002/cam4.5062

Internet

https://doi.org/10.1002/cam4.5062

Similar Items